The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mary Elizabeth Strek and Ayodeji Adegunsoye.
Mary Elizabeth Strek
Connection Strength
10.204
Ayodeji Adegunsoye
  1. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
    View in: PubMed
    Score: 0.853
  2. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).
    View in: PubMed
    Score: 0.616
  3. Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis. Front Med (Lausanne). 2017; 4:170.
    View in: PubMed
    Score: 0.588
  4. Therapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.
    View in: PubMed
    Score: 0.542
  5. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
    View in: PubMed
    Score: 0.527
  6. Transcriptomic Profiling of Long COVID in Interstitial Lung Disease Patients Reveals Dysregulation of Mitochondrial Oxidative Phosphorylation. Am J Respir Cell Mol Biol. 2025 Apr 30.
    View in: PubMed
    Score: 0.248
  7. Implementation of an Interstitial Lung Abnormality Clinic and Multidisciplinary Discussion. Respir Care. 2024 04 22; 69(5):603-607.
    View in: PubMed
    Score: 0.231
  8. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2023 08 01; 325(2):L233-L243.
    View in: PubMed
    Score: 0.218
  9. Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nat Commun. 2023 03 17; 14(1):1489.
    View in: PubMed
    Score: 0.214
  10. Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease. Cureus. 2022 Apr; 14(4):e23808.
    View in: PubMed
    Score: 0.200
  11. Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard. Front Med (Lausanne). 2022; 9:864658.
    View in: PubMed
    Score: 0.200
  12. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
    View in: PubMed
    Score: 0.195
  13. Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease. ERJ Open Res. 2021 Oct; 7(4).
    View in: PubMed
    Score: 0.195
  14. Correction to: Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Nov; 31(11):8825.
    View in: PubMed
    Score: 0.195
  15. Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Oct; 31(10):7295-7302.
    View in: PubMed
    Score: 0.187
  16. Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis. Eur Respir J. 2021 03; 57(3).
    View in: PubMed
    Score: 0.186
  17. Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases. Chest. 2021 07; 160(1):209-218.
    View in: PubMed
    Score: 0.185
  18. Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.
    View in: PubMed
    Score: 0.176
  19. CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.
    View in: PubMed
    Score: 0.176
  20. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
    View in: PubMed
    Score: 0.164
  21. Reply to Lescoat et al. and to Khamis et al. Am J Respir Crit Care Med. 2019 04 15; 199(8):1041-1042.
    View in: PubMed
    Score: 0.163
  22. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.
    View in: PubMed
    Score: 0.162
  23. CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AJR Am J Roentgenol. 2018 May; 210(5):1034-1041.
    View in: PubMed
    Score: 0.151
  24. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.
    View in: PubMed
    Score: 0.148
  25. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
    View in: PubMed
    Score: 0.147
  26. De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 09; 152(3):683-685.
    View in: PubMed
    Score: 0.146
  27. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ Open Res. 2017 Jul; 3(3).
    View in: PubMed
    Score: 0.145
  28. CT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017 Dec; 27(12):5127-5135.
    View in: PubMed
    Score: 0.144
  29. Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med. 2017 Jul; 141(7):960-969.
    View in: PubMed
    Score: 0.142
  30. CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.
    View in: PubMed
    Score: 0.141
  31. A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. Eur Respir J. 2016 12; 48(6):1813-1814.
    View in: PubMed
    Score: 0.138
  32. Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function. Front Immunol. 2016; 7:516.
    View in: PubMed
    Score: 0.138
  33. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
    View in: PubMed
    Score: 0.138
  34. Comprehensive Care of the Lung Transplant Patient. Chest. 2017 07; 152(1):150-164.
    View in: PubMed
    Score: 0.137
  35. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.
    View in: PubMed
    Score: 0.133
  36. Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 Apr 10.
    View in: PubMed
    Score: 0.062
  37. Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets. medRxiv. 2025 Feb 02.
    View in: PubMed
    Score: 0.061
  38. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
    View in: PubMed
    Score: 0.060
  39. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):639-647.
    View in: PubMed
    Score: 0.059
  40. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):455-464.
    View in: PubMed
    Score: 0.059
  41. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):444-454.
    View in: PubMed
    Score: 0.059
  42. Hypersensitivity Pneumonitis on Thin-Section Chest CT Scans: Diagnostic Performance of the ATS/JRS/ALAT versus ACCP Imaging Guidelines. Radiol Cardiothorac Imaging. 2024 Aug; 6(4):e230068.
    View in: PubMed
    Score: 0.059
  43. Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. Am J Respir Crit Care Med. 2024 05 01; 209(9):1121-1131.
    View in: PubMed
    Score: 0.058
  44. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1111-1120.
    View in: PubMed
    Score: 0.058
  45. Risk Factors for Hospital Readmission in Patients With Interstitial Lung Disease. Respir Care. 2024 04 22; 69(5):586-594.
    View in: PubMed
    Score: 0.058
  46. A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis. J Heart Lung Transplant. 2024 Jul; 43(7):1174-1182.
    View in: PubMed
    Score: 0.057
  47. Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. ERJ Open Res. 2024 Jan; 10(1).
    View in: PubMed
    Score: 0.057
  48. Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis. medRxiv. 2024 Jan 15.
    View in: PubMed
    Score: 0.057
  49. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).
    View in: PubMed
    Score: 0.056
  50. Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. Chest. 2024 Mar; 165(3):621-631.
    View in: PubMed
    Score: 0.056
  51. Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis. medRxiv. 2023 Jul 24.
    View in: PubMed
    Score: 0.055
  52. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 06 01; 207(11):1515-1524.
    View in: PubMed
    Score: 0.054
  53. Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies. medRxiv. 2023 May 11.
    View in: PubMed
    Score: 0.054
  54. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 05; 163(5):1156-1165.
    View in: PubMed
    Score: 0.053
  55. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. Lancet Respir Med. 2023 01; 11(1):65-73.
    View in: PubMed
    Score: 0.051
  56. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6).
    View in: PubMed
    Score: 0.051
  57. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022 08; 27(8):635-644.
    View in: PubMed
    Score: 0.050
  58. Rituximab for interstitial pneumonia with autoimmune features at two medical centres. Rheumatol Adv Pract. 2021 Nov; 5(Suppl 2):ii1-ii9.
    View in: PubMed
    Score: 0.049
  59. Hospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021 Sep 30; 22(1):257.
    View in: PubMed
    Score: 0.048
  60. Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208.
    View in: PubMed
    Score: 0.048
  61. Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging. J Clin Med. 2021 Jun 17; 10(12).
    View in: PubMed
    Score: 0.047
  62. Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype. Eur Respir J. 2020 Dec; 56(6).
    View in: PubMed
    Score: 0.046
  63. Automated CT Analysis of Major Forms of Interstitial Lung Disease. J Clin Med. 2020 Nov 23; 9(11).
    View in: PubMed
    Score: 0.046
  64. Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations. Blood Adv. 2020 10 13; 4(19):4873-4886.
    View in: PubMed
    Score: 0.045
  65. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574.
    View in: PubMed
    Score: 0.043
  66. Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.
    View in: PubMed
    Score: 0.043
  67. Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.
    View in: PubMed
    Score: 0.042
  68. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723.
    View in: PubMed
    Score: 0.041
  69. Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).
    View in: PubMed
    Score: 0.041
  70. Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. Respir Med. 2019 01; 146:23-27.
    View in: PubMed
    Score: 0.040
  71. Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.
    View in: PubMed
    Score: 0.038
  72. N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC Pulm Med. 2018 Feb 08; 18(1):30.
    View in: PubMed
    Score: 0.038
  73. ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.